Plain-English translation of NCT05567198 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Women with severe lupus often need a chemotherapy drug called cyclophosphamide to control their disease, but this medication can damage the ovaries and affect fertility. This study is testing whether leuprolide acetate, a hormone medication, can protect the ovaries when given together with cyclophosphamide. Researchers will compare ovarian health in women who received the protective medication with those who didn't.
Cyclophosphamide can harm ovarian function and cause infertility, which is a major concern for women of childbearing age with lupus. This medication may reduce that damage, but doctors don't yet have solid evidence that it works—this study aims to find out.
You likely qualify if…
You likely don't qualify if…
This is primarily a data collection and survey study, so you won't receive new medication—researchers will review your existing medical records and ask you to complete questionnaires about your reproductive health and menstrual history. Participation involves filling out surveys and allowing the research team to access your medical records to compare ovarian function outcomes between those who received the protective medication and those who didn't.
AI-generated summary from trial data · Jun 21, 2026 · Not medical advice
United States